[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366878-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366878-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","current-and-emerging-protein-biomarkers-for-the-diagnosis-and-prognosis-of-head-and-neck-cancer","Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer","","Head and neck cancer comprises heterogeneous malignancies, with oral squamous cell carcinoma (OSCC) as the most common subtype and a rising incidence. Although localized OSCC can be curable, long-term prognosis remains poor due to delayed diagnosis and constrained targeted therapies. The review emphasizes the need to define molecular biomarkers that track OSCC progression, particularly in dysplastic lesions before malignant transformation. It summarizes candidate protein biomarkers linked to clinicopathological features and clinical outcomes and highlights their roles in carcinogenic pathways, supporting earlier detection and improved prognostic accuracy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/current-and-emerging-protein-biomarkers-for-the-diagnosis-and-prognosis-of-head-and-neck-cancer/366878/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/current-and-emerging-protein-biomarkers-for-the-diagnosis-and-prognosis-of-head-and-neck-cancer/366878.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does OSCC prognosis remain poor despite curative potential in localized disease?","Question",{"text":63,"@type":64},"Overall OSCC prognosis has not improved substantially due to frequently delayed diagnosis and limited targeted treatment options.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What risk factors are associated with OSCC development?",{"text":68,"@type":64},"Risk factors include exposure to carcinogens such as alcohol and tobacco products, as well as human papillomavirus (HPV) infection.",{"name":70,"@type":61,"acceptedAnswer":71},"How can protein biomarker panels help in managing head and neck cancers?",{"text":72,"@type":64},"A diverse panel may enhance early detection and improve prognostic accuracy, while some individual biomarkers could serve as therapeutic targets for personalized approaches.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366878,1790869068,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Review  \nCurrent and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer  \nErin Zou 1, Chethana Venkatraman 1, Jackson Sweeney 1, Katy Flannery 1, Samuel Lailer 1, Donna Mehdiyar 1, Komal Parikh 1, Maryam Salik 1, Brianna Baughman 1 and Hilal Arnouk 2, *  \nAcademic Editor: Christos Yapijakis  \nReceived: 7 November 2025  \nRevised: 6 December 2025  \nAccepted: 10 December 2025  \nPublished: 15 December 2025  \nCitation: Zou, E.; Venkatraman, C.; Sweeney, J.; Flannery, K.; Lailer, S.; Mehdiyar, D.; Parikh, K.; Salik, M.; Baughman, B.; Arnouk, H. Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer. Genes 2025, 16, 1493 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)genes16121493  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL 60515, USA  \n2 Illinois College of Osteopathic Medicine at The Chicago School, Chicago, IL 60661, USA  \n* [Correspondence: harnouk@thechicagoschool.edu](Correspondence: harnouk@thechicagoschool.edu)  \nAbstract  \nHead and neck cancer represents a heterogeneous group of malignancies. Oral squamous cell carcinoma (OSCC) is the most prevalent form of head and neck cancer, with a rising incidence in recent years. Risk factors for developing OSCC include exposure to carcinogens, such as alcohol and tobacco products, that can lead to molecular alterations in the oral mucosa and progression from premalignant lesions to invasive phenotypes. Despite the relative curative potential of localized OSCC, the overall prognosis of OSCC has not significantly improved for decades due to a frequently delayed diagnosis and limited targeted treatment options. There remains a need to better characterize the molecular biomarkers of OSCC progression, especially in dysplastic mucosal lesions, before their malignant transformation. In this review, we discuss several molecular biomarkers highly implicated in OSCC tumorigenesis that have demonstrated correlation with clinicopathological parameters and clinical outcomes. These biomarkers are typically involved in vital pathways of carcinogenesis, including cell cycle control, growth factor signaling, and stress responses. They include ubiquitous cancer biomarkers such as p53 and PTEN, as well as those more specific to OSCC, such as DJ-1 and Cornulin. Collectively, we envision that a diverse panel of these biomarkers can provide the greatest clinical benefit in enhancing early detection and prognostic accuracy, while some individual biomarkers may also serve as therapeutic targets for personalized approaches to head and neck cancers.  \nKeywords: head and neck cancer; oral squamous cell carcinoma; head and neck squamous cell carcinoma; prognostic biomarkers; precision medicine oncology; molecular pathology; targeted treatments; tumor progression; DJ-1; Cornulin  \n1. Introduction  \nHead and neck squamous cell carcinoma (HNSCC) represents a set of malignancies arising from the mucosal linings of the upper aerodigestive tract. Among these, oralsquamous cell carcinoma (OSCC) is the predominant subtype and accounts for around 90% of oral malignancies [1] . The Global Cancer Observatory (GCO) reported more than 389 thousand cases of OSCC and about 188 thousand deaths worldwide in 2022, reflecting an increase in incidence and mortality [2] . The relatively poor prognosis of OSCC is attributable in large part to delayed diagnosis, evidenced by a markedly stratified 5-year survival rate of greater than 80% in localized early disease and less than 30% in advanced distant disease [3] .  \nOSCC develops in the mucosal lining o","cbCaihWS8U3kDNXz","https://ap.wps.com/l/cbCaihWS8U3kDNXz","pdf",1240602,28,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"Why does OSCC prognosis remain poor despite curative potential in localized disease?\",\"answer\":\"Overall OSCC prognosis has not improved substantially due to frequently delayed diagnosis and limited targeted treatment options.\"},{\"question\":\"What risk factors are associated with OSCC development?\",\"answer\":\"Risk factors include exposure to carcinogens such as alcohol and tobacco products, as well as human papillomavirus (HPV) infection.\"},{\"question\":\"How can protein biomarker panels help in managing head and neck cancers?\",\"answer\":\"A diverse panel may enhance early detection and improve prognostic accuracy, while some individual biomarkers could serve as therapeutic targets for personalized approaches.\"}]","Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer | PDF",1790168087,71,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eaa2c092aed156db929fefb5273d0595.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/927fcb732febcd8201645cb8b90ec950.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/123722b222d5b0a743a0a5a23c71c461.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a478c2a4d525fdb7d8c4fea4de0176bd.webp",980,1385]